Status:
UNKNOWN
Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Head and Neck Cancer
Esophageal Cancer
Eligibility:
All Genders
18-90 years
Brief Summary
This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.
Eligibility Criteria
Inclusion
- Head and neck cancers
- Esophageal cancer
- Undergoing anti-cancer treatments
Exclusion
- No distant metastasis
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00318604
Last Update
May 12 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.